David Hoang

Q: What is David Hoang's success rate?

David Hoang currently has a success rate of 84.7019912648382.

Q: What is the average return of David Hoang's calls?

Their stock ratings have generated an average return of 42.092622937101275.

Deutsche Bank | Healthcare

David Hoang is an analyst from Deutsche Bank specializing in the Healthcare sector. Ranked #420 out of 4746 analysts, they have issued 15 stock ratings with a success rate of 84.70% and an average return of 42.09%.

With 15 ratings to date, David Hoang is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 84.70% and an average return of 42.09%, highlighting promising potential as their track record develops further.

#420

Out of 4746

Total Ratings

+84.70%

Success Rate

+42.09%

Average Return

Recent Ratings Analysis

KYMR

Hold

Jul 30, 2026

Target

$120.00

Current

$105.25

Performance

—

David Hoang rated KYMR as Hold on Jul 30, 2026, setting a price target of 120. The Hold stance appears justified, as shares hovered around 105.25 with a % move.

DNLI

Buy

Jul 16, 2026

Target

$35.00

Current

$23.85

Performance

4.93%

On Jul 16, 2026, DNLI was given a Buy rating by David Hoang, with a target price of 35. The stock traded sideways with a 4.93% move, keeping the bullish thesis unresolved.

HRMY

Hold

Jun 30, 2026

Target

$36.00

Current

$35.86

Performance

-1.51%

HRMY received a Hold rating from David Hoang on Jun 30, 2026, aiming for 36. Shares remained flat at 35.86, aligning with the neutral rating.

APGE

Hold

Jun 23, 2026

Target

$135.00

Current

$134.20

Performance

0.99%

On Jun 23, 2026, David Hoang published a Hold outlook on APGE, with a target of 135. Sideways action left the Hold view intact, with no major move since 134.2.

SYRE

Buy

Jun 23, 2026

Target

$135.00

Current

$97.87

Performance

0.84%

David Hoang on Jun 23, 2026 assigned SYRE a Buy rating, with a price target of 135. The recommendation remains pending validation as shares consolidate around 97.87.

PRAX

Buy

Jun 02, 2026

Target

$374.00

Current

$291.03

Performance

—

On Jun 02, 2026, David Hoang reaffirmed PRAX with a Buy rating, targeting 374. Market indecision has kept the 374 target in a holding pattern.

ATAI

Buy

Mar 27, 2026

Target

$12.00

Current

$7.18

Performance

114.33%

ATAI was rated Buy by David Hoang on Mar 27, 2026, with a price objective of 12. A bullish response from the market helped close the gap of 4.82 to the target.

XENE

Buy

Mar 10, 2026

Target

$90.00

Current

$63.10

Performance

4.11%

On Mar 10, 2026, David Hoang initiated coverage on XENE with a Buy rating and target of 90. Neutral price movement of 4.11% leaves room for interpretation.

ALKS

Buy

Nov 13, 2025

Target

$45.00

Current

$48.34

Performance

55.89%

David Hoang issued a Buy recommendation for ALKS on Nov 13, 2025, price target set at 45. Investors following the Buy call captured upside momentum, with shares now at 48.34.

SRPT

Sell

Aug 15, 2025

Target

$12.00

Current

$15.54

Performance

-28.77%

On Aug 15, 2025, SRPT was evaluated by David Hoang, who gave a Sell rating and target of 12. The recommendation was proven wrong by upward action toward 12.

AVDL

Buy

Feb 11, 2025

Target

$12.00

Current

$21.64

Performance

140.44%

David Hoang rated AVDL as Buy on Feb 11, 2025, setting a price target of 12. The call has proven timely, with shares rising 140.44% toward the price target of 12.

BHVN

Buy

Feb 11, 2025

Target

$65.00

Current

$13.43

Performance

-68.42%

On Feb 11, 2025, BHVN was given a Buy rating by David Hoang, with a target price of 65. Despite the Buy call, shares fell from 13.43 to 13.43, challenging the optimistic stance.

AXSM

Buy

Feb 11, 2025

Target

$176.00

Current

$227.42

Performance

72.03%

AXSM received a Buy rating from David Hoang on Feb 11, 2025, aiming for 176. Momentum has favored the Buy call, with shares climbing from 227.42 to 227.42, rewarding those who trusted the recommendation.

NBIX

Hold

Aug 02, 2024

Target

$158.00

Current

$180.79

Performance

18.06%

On Aug 02, 2024, David Hoang published a Neutral outlook on NBIX, with a target of 158. The Hold call missed some of the bullish momentum as shares advanced toward 158.

LBPH

Buy

Aug 02, 2024

Target

$50.00

Current

$59.98

Performance

82.59%

David Hoang on Aug 02, 2024 assigned LBPH a Buy rating, with a price target of 50. The Buy call aligned well with market performance, producing a gain of 82.59%.

ABOS

Buy

Jul 25, 2024

Target

$7.00

Current

$2.11

Performance

-38.12%

On Jul 25, 2024, David Hoang reaffirmed ABOS with a Buy rating, targeting 7. Shares slid 38.12% despite the recommendation, highlighting downside risks.

ACAD

Buy

May 09, 2024

Target

$30.00

Current

$26.34

Performance

73.18%

ACAD was rated Buy by David Hoang on May 09, 2024, with a price objective of 30. A bullish response from the market helped close the gap of 3.66 to the target.

Frequency Asked Questions

Who is David Hoang?

David Hoang is an analyst from Deutsche Bank specializing in the Healthcare sector.

What is David Hoang's success rate?

David Hoang currently has a success rate of +84.70%.

How many ratings has David Hoang issued?

David Hoang has issued 15 stock ratings so far.

What is the average return of David Hoang's calls?

Their stock ratings have generated an average return of +42.09%.

What is David Hoang's ranking?

David Hoang is ranked #420 out of 4746 analysts.

What types of ratings does David Hoang give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Hoang?

You can follow David Hoang by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Hoang?

Their latest rating was a Hold on KYMR issued on 2026-07-30.